EP1038012A2 - Procede de production de plantes transgeniques par biosynthese modifiee d'acide 5-aminolevulinique, et procede d'identification d'effecteurs de la synthese d'acide 5-aminolevulinique - Google Patents

Procede de production de plantes transgeniques par biosynthese modifiee d'acide 5-aminolevulinique, et procede d'identification d'effecteurs de la synthese d'acide 5-aminolevulinique

Info

Publication number
EP1038012A2
EP1038012A2 EP98964495A EP98964495A EP1038012A2 EP 1038012 A2 EP1038012 A2 EP 1038012A2 EP 98964495 A EP98964495 A EP 98964495A EP 98964495 A EP98964495 A EP 98964495A EP 1038012 A2 EP1038012 A2 EP 1038012A2
Authority
EP
European Patent Office
Prior art keywords
alas
plant
transgenic
plants
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98964495A
Other languages
German (de)
English (en)
Inventor
Frank Schmidt
Günter Donn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Aventis CropScience GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis CropScience GmbH filed Critical Aventis CropScience GmbH
Publication of EP1038012A2 publication Critical patent/EP1038012A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)

Definitions

  • the invention relates to processes for the production of transgenic plant cells and plants with modified 5-aminolevulinic acid biosynthesis, the use of nucleic acid molecules coding for a protein with the function of a 5-aminolevulinic acid synthase (ALAS) for the production of transgenic plant cells and plants, and processes for identifying effectors of the and the use of effectors of 5-aminolevulinic acid biosynthesis, in particular the use of herbicidally active inhibitors of plant 5-aminolevulinic acid biosynthesis in plant crops, preferably in transgenic plant crops.
  • UAS 5-aminolevulinic acid synthase
  • herbicides to control undesirable plant growth on agricultural crop areas is widespread in modern agriculture. Despite the use of herbicides, it is not always possible to control weeds and harmful plants efficiently, since highly effective herbicides with a broad spectrum of activity often have an intolerance to useful plants or the emergence of resistance phenomena can also be observed.
  • Herbicide tolerance can be created by modifying the plant enzyme which is inhibited by the selected herbicide so that it is less sensitive to the herbicidal active ingredient.
  • WO 95/3459 describes plants which express the genes of variants of the protoporphyrinogen oxidase and thereby an increased tolerance to herbicidal diphenyl ether and other plant inhibitors Have protoporphyrinogen oxidase.
  • Herbicide tolerance was also achieved by introducing enzymes by genetic engineering into the metabolism of crop plants which can deactivate the applied herbicidal active ingredient (e.g. EP-A-0 242 236; EP-A-0 343 100).
  • enzymes by genetic engineering into the metabolism of crop plants which can deactivate the applied herbicidal active ingredient (e.g. EP-A-0 242 236; EP-A-0 343 100).
  • ALA 5-aminolevulinic acid
  • the C5 metabolic pathway (C5 pathway) consists of three reaction steps, catalyzed by the enzymes glutamyl-tRNA synthetase (EC 6.1.1.17), glutamyl-tRNA reductase (EC 1.2.1.-.) And glutamate-1-semialdehyde aminotransferase ( GSAAT, EC 5.4.3.8.) And is localized in plants in the plastids.
  • the GSAAT was isolated from various organisms and the structural genes of the enzyme were cloned, e.g. B. from the plants Arabidopsis thaliana, tobacco, barley and soybean.
  • the vegetable GSAAT can be produced recombinantly by heterologous expression of its cDNA (Berry-Lowe et al. (1992) Plant Physiol. 99: 1597-1603).
  • GSAAT is inhibited by 3-amino-2,3-dihydrobenzoic acid.
  • the treated plants can no longer synthesize ALA and therefore no longer the porphyrin compounds chlorophyll, heme and siroheme (Beale (1990) Plant Physiology 93: 1273-1279).
  • Such plants develop strong chlorotic tissue, which is destroyed in the light.
  • An alternative biosynthetic pathway for the production of ALA exists in animals, fungi, yeasts and the purple bacteria of the alpha group, e.g. B. Rhodobacter sphaeroides or Rhodobacter capsulatus.
  • the ALAS has been isolated from a variety of organisms.
  • the structural gene of the ALAS has also been isolated from, among others, Saccharomyces cerevisiae, Rhodobacter sphaeroides, Rhodobacter capsulatus, humans and mice.
  • the task was to provide a practicable resistance principle against inhibitors of plant 5-amino acid levulinic acid synthesis and a rational, practicable method for finding such inhibitors.
  • the rate of synthesis of ALA in the plant must be sufficient to meet the need for ALA for the physiologically necessary porphyrin biosynthesis ensure.
  • the production of ALA must not be so high that there is direct or indirect damage to the plant. Therefore the C5 biosynthetic pathway for ALA in plants is regulated.
  • plants can be produced which are resistant to herbicidally active inhibitors of the C5 pathway, e.g. against inhibitors of GSAAT, if one expresses certain or complementary heterologous ALAS genes in useful plants, so that non-selective inhibitors of the C5 pathway can be used as herbicides in said transgenic useful plant cultures.
  • the present invention therefore provides a method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, in which the metabolic pathway specifically inhibited by a herbicide is circumvented by a heterologous gene expression which complements or substitutes the inhibition.
  • the plants are equipped with one or more heterologous nucleic acid molecules with one or more additional or alternative biosynthetic steps which lead to the end product of the inhibited metabolic pathway, so that the transgenic plant is resistant to the herbicidally active inhibitor of the C5 metabolic pathway results.
  • This alternative pathway gives the transgenic plants that have ALAS activity the desired resistance to non-selective herbicides that inhibit the formation of aminolevulinic acid within the C5 pathway, e.g. by inhibiting the GSAAT enzyme by bypassing the metabolic step blocked by the herbicidal active ingredient. Resistance to heterologous ALAS activity can also be obtained in the transgenic plants against inhibitors of glutamyl-tRNA reductase.
  • the subject of the invention is therefore a process for the production of transgenic plants, transgenic plant cells, transgenic plant parts, transgenic plant seeds, transgenic propagation material with modified 5-aminolevulinic acid biosynthesis, comprising one or more functionally active nucleic acid molecules coding for a protein with the function of an ALAS selected from the group of feedback-regulated ALAS, animal ALAS and bacterial ALAS, preferably a feedback-regulated ALAS, particularly preferably ALAS from purple bacteria, active fragments thereof or an antisense or complementary sequence thereof, which are prepared by a process known per se for the production of transgenic plant cells or plants, Plant parts, plant seeds or propagation material are stably integrated into the plant genome.
  • genome includes the entire genetic material of a plant, i.e. In addition to the core DNA, the genetic material of all organelles of the plant cells.
  • monocot plants in particular maize plants, can be produced which are resistant to herbicidally active inhibitors of the C5 pathway, for example to GSAAT inhibitors, if heterologous ALAS genes are substitutive in these crop plants or expressed in a complementary manner so that non-selectively active inhibitors of the C5 metabolic pathway can be used as herbicides in the said transgenic crops.
  • the invention therefore also relates to a process for producing transgenic plants, transgenic plant cells, transgenic plant seeds, transgenic propagation material with modified 5-aminolevulinic acid biosynthesis, comprising one or more functionally active nucleic acid molecules coding for a protein with the function of an ALAS, preferably a feedback regulated ALAS, particularly preferably of ALAS from purple bacteria, of active fragments thereof or an antisense or complementary sequence thereof, which are stably integrated into the plant genome by a process known per se for the production of transgenic plant cells or plants, plant parts, plant seeds or propagation material, characterized in that the transgenic plant is a monocot plant, preferably a maize plant.
  • Another object of the invention is the use of at least one nucleic acid molecule (NS) coding for a protein with the function of an ALAS, selected from the group of feedback-regulated ALAS, animal ALAS and bacterial ALAS, preferably a feedback-regulated ALAS, particularly preferably an ALAS Purple bacteria, an active fragment thereof or an antisense or complementary sequence thereof for the production of transgenic plant cells or plants with modified 5-aminolevulinic acid biosynthesis, preferably for the expression of a protein with the function of an ALAS according to the invention or an active fragment thereof in transgenic plant cells or plants or also preferred for the production of transgenic Plant cells or plants whose expression of a protein with the function of a GSAAT or an active fragment thereof is suppressed or inhibited.
  • NS nucleic acid molecule
  • Another object of the invention is the use of at least one nucleic acid molecule (NS) coding for a protein with the function of an ALAS, preferably a feedback-regulated ALAS, particularly preferably an ALAS from purple bacteria, an active fragment thereof or an antisense or complementary sequence thereof for the production of transgenic plant cells or plants with modified 5-aminolevulinic acid biosynthesis, preferably for the expression of a protein with the function of an ALAS according to the invention or an active fragment thereof in transgenic plant cells or plants or also preferably for the production of transgenic plant cells or plants whose expression of a protein with the Function of a GSAAT or an active fragment is suppressed or inhibited therefrom, characterized in that the transgenic plant is a monocotyledonous plant, preferably a maize plant.
  • NS nucleic acid molecule
  • genes coding for proteins with ALAS activity can be used for the production of transgenic plants which are able to produce ALA by means of the Shemin metabolic pathway.
  • Nucleic acid sequences coding for proteins with ALAS activity are derived from amino acid sequences of proteins with ALAS activity or their genes from, for example, animals and bacteria, or generally from feedback-regulated ALAS from prokaryotic or eukaryotic organisms or their active fragments, for example the ALAS from the purple bacteria of the alpha group such as Rhodobacter sphaeroides, Seq. ID No. 1 or Seq. ID No. 2, (Neidle & Kaplan (1993) Journal of Bacteriology 175: 2292-2303) or Rhodobacter capsulatus, Seq. ID No. 3 (Hornberger et al. (1990) Mol. Gen. Genet. 221: 371-378).
  • a balanced synthesis of ALA can be ensured, for example, in the following way, so that the term feedback-regulated in connection with the biological activity of ALAS is to be understood as explained below:
  • nucleic acids (NS) coding for proteins with ALAS activity which have a pronounced feedback regulation by heme
  • heme is an essential product made from ALA.
  • the synthesis rate of heme is linked to the provision of ALA and thus reflects the synthesis capacity for the intermediate ALA and thus indirectly also the possible substrate flow into the chlorophyll biosynthesis.
  • ALAS-coding NS from Rhodobacter sphaeroides, Rhodobacter capsulatus and other purple bacteria of the alpha group are suitable.
  • the feedback regulation of the enzymatic activity of a heterologous ALAS can take place in the plant cell, for example in plastids and in the mitochondria, since the regulatory active compounds, for example heme, are formed in these organelles starting from 5-aminolevulinate (ALA). It is therefore particularly advantageous to express a heterologous NS coding for a feedback-regulated protein with ALAS activity in such a way that the functionally intact expression products (ALAS) are present in the plastids or mitochondria.
  • ALAS functionally intact expression products
  • ALA synthesized in mitochondria can be exported to the plastids, where the enzymes of the subsequent tetrapyrrole biosynthesis are located, through the transport systems present in the plant.
  • the localization of an ALAS in plastids can be achieved, for example, by an NS coding for a protein with ALAS activity under the control of an in Plastid active promoter is inserted into the piastome of a plant by methods known to those skilled in the art. All promoters constitutively active in plastids are available as promoters, preferably, for example, the expression signal sequences of the psM cassette (Staub & Maliga (1993) EMBO Journal 12: 601-606; Zoubenko et al. (1994) Nucleic Acids Research 22: 3819-3824) and the Prrn promoter (Svab & Maliga (1993) Proc. Natl. Acad. Sci. USA 90: 913-917).
  • the promoters can e.g. according to known methods, together with the heterologous NS coding for a protein with the function of an ALAS, are inserted into the piastom or the heterologous NS is inserted into the piastom in such a way that it is under the control of an already existing promoter (Staub & Maliga (1995) Plant Journal 7: 845-848).
  • plastid localization of an ALAS can also be achieved by first synthesizing the ALAS in the cytoplasm with a suitable plastid targeting sequence (transit peptide) and importing it into the plastids during or after its synthesis.
  • a suitable plastid targeting sequence transit peptide
  • numerous promoters, plastid targeting sequences and fusion strategies for NS coding for a targeting sequence and NS coding for a protein with ALAS activity are available to the person skilled in the art.
  • promoters which are able to bring about the transcription of DNA sequences in plants.
  • Such promoters are preferably derived from the genome of plants or phytopathogenic viruses, for example the CaMV35S promoter and its derivatives, preferably from the piastome, likewise preferably from core DNA, particularly preferably from the piastom of plants.
  • the promoter used must allow an expression level of the ALAS gene which is sufficient to impart resistance to the transgenic plant to inhibitors of the C5 biosynthetic pathway for ALA.
  • the NS coding for a protein with ALAS activity is preferably cloned under the control of a promoter as a fusion with a DNA sequence coding for a plastid transit peptide, so that the primary translation product is provided at the N-terminal with a plastid transit peptide and is imported into plastids.
  • plastid transit peptides preference is given to using peptide sequences which, as an N-terminal fusion, bring about the translocation of polypeptide chains from the cytoplasm into plastids and are cleaved off during or after this process.
  • Particularly preferred as the transit peptide for proteins with ALAS activity is the transit peptide of the small subunit of ribulose bisphosphate carboxylase.
  • the localization of an ALAS according to the invention in mitochondria can be achieved by first synthesizing the protein in the cytoplasm with a suitable mitochondrial targeting sequence and importing it into the mitochondrion during or after its synthesis.
  • a suitable mitochondrial targeting sequence and importing it into the mitochondrion during or after its synthesis.
  • Numerous promoters, mitochondrial targeting sequences and fusion strategies for sequences coding for a targeting sequence and sequences coding for a protein with ALAS activity are also available to the person skilled in the art.
  • the same promoters can be used which have been described for the localization of the expression products in the plastid.
  • the NS coding for a protein with ALAS activity is preferably cloned under the control of a promoter as a fusion with a DNA sequence coding for a mitochondrial transit peptide, so that the primary translation product is provided with a mitochondrial transit peptide and is imported into mitochondria.
  • peptide sequences which, as an N-terminal fusion, are the translocation of polypeptide chains effect from the cytoplasm in mitochondria and be split off during or after this process.
  • a further subject of the invention is therefore a process for the production of transgenic plants, transgenic plant cells, transgenic plant parts, transgenic plant seeds, transgenic propagation material with modified 5-aminolevulinic acid biosynthesis containing one or more functionally active nucleic acid molecules coding for a protein with the function of an ALAS, selected from the Group of feedback-regulated ALAS, animal ALAS and bacterial ALAS, preferably a feedback-regulated ALAS, particularly preferably ALAS from purple bacteria, active fragments thereof or an antisense or complementary sequence thereof, in which said nucleic acid molecules are under the control of a feedback-regulated Promoters and the use of a feedback-regulated promoter, preferably a promoter of a plant GSAAT or glutamyl-tRNA reductase in a method according to the invention for the production of transgenic plant cells or plants Modified 5-aminolevulinic acid biosynthesis.
  • an ALAS selected from the Group of feedback-regulated ALAS, animal ALAS and bacterial ALAS, preferably a feedback-regulated
  • the invention also relates to a process for producing transgenic plants, transgenic plant cells, transgenic plant parts, transgenic plant seeds, transgenic propagation material with modified 5-aminolevulinic acid biosynthesis containing one or more functional active nucleic acid molecules coding for a protein with the function of an ALAS, preferably a feedback -regulated ALAS, particularly preferably of ALAS from purple bacteria, of active fragments thereof or an antisense or complementary sequence thereof, in which said nucleic acid molecules are under the control of a feedback-regulated promoter and the use of a feedback-regulated promoter, preferably a promoter of a vegetable GSAAT or Glutamyl-tRNA reductase in a method according to the invention for the production of transgenic plant cells or plants with modified 5-aminolevulinic acid Biosynthesis, characterized in that the transgenic plant is a monocot plant, preferably a maize plant.
  • the ALAS gene according to the invention under the control of a promoter specifically regulated in plants in order to achieve a targeted, feedback-regulated expression.
  • a promoter specifically regulated in plants e.g., the promoters of the enzymes of plant porphyrin biosynthesis, preferably the promoters of the genes coding for glutamyl-tRNA reductase and GSAAT, e.g. by using promoter sequences which are in the region of approximately 2 kb (kilobase) long, upstream (in the 3 'direction) nucleic acid segments of the coding regions of said genes.
  • NS coding for a heterologous protein with ALAS activity as well as the plant genes coding for glutamyl-tRNA reductase and GSAAT is only expressed when there is a physiological need for ALA.
  • an NS coding for an ALAS feedback-regulated at the protein and gene expression level is also particularly advantageous, i.e. to both express an ALAS protein which has a feedback-regulated enzymatic activity and to place the gene expression of the feedback-regulated ALAS under the control of a feedback-regulated promoter.
  • NS coding for proteins with ALAS activity can be isolated or synthetically produced from animal, fungal or suitable bacterial organisms.
  • the nucleic acid molecules will preferably be cloned using DNA or RNA from the respective donor organism by means of common molecular biological methods (Ausubel et al. In “Current Protocols in Molecular Biology", John Wiley & Sons Inc., ISBN 0-471-50338-X).
  • the sequence of the NS can also be changed, shortened or expanded in many ways using common molecular biological methods, so that devatization, for example by mutation, deletion, substitution or insertion.
  • the invention also relates to non-naturally occurring chimeric genes, at least comprising a promoter suitable for the expression of an ALAS according to the invention in plants, which is functionally coding for a DNA molecule for a protein with the function of an ALAS or an active fragment thereof or an antisense or complementary sequence thereof is fused.
  • the invention also relates to recombinant vectors, in particular plasmids, cosmids, viruses and other vectors common in genetic engineering, containing at least one non-naturally occurring chimeric gene according to the invention.
  • nucleic acid molecules contained in the vectors are linked to regulatory elements which ensure the transcription and synthesis of a translatable RNA in plant cells.
  • the invention also relates to transgenic plant cells which have been transformed and / or genetically modified with a DNA molecule coding for a protein having the function of an ALAS according to the invention or an active fragment thereof or an antisense or complementary sequence thereof or a chimeric gene or vector according to the invention , and cells which are derived from cells transformed and / or modified in this way and which contain a nucleic acid molecule to be used according to the invention or a gene or vector according to the invention.
  • the invention also relates to transgenic plant cells which transform with a DANN molecule coding for a protein with the function of an ALAS or an active fragment thereof or an antisense or complementary sequence thereof or a chimeric gene or vector according to the invention and / or are genetically modified, and cells derived from such transformed and / or modified cells, which contain a nucleic acid molecule to be used according to the invention or a gene or vector according to the invention, characterized in that the transgenic plant is a monocotyledonous plant, preferably a maize plant .
  • the invention also relates to the production of transgenic plants, transgenic plant cells, transgenic plant parts, transgenic plant seeds, transgenic propagation material, i.e. obtainable, preferably obtained, by a method according to the invention, containing a DNA molecule coding for a protein with the function of an ALAS selected from the group of feedback-regulated ALAS, animal ALAS and bacterial ALAS, or an active fragment thereof or an antisense or complementary Sequence thereof, especially crops or ornamental plants.
  • the invention also relates to the production of transgenic plants, transgenic plant cells, transgenic plant parts, transgenic plant seeds, transgenic propagation material, i.e. obtainable, preferably obtained, by a method according to the invention, containing a DNA molecule coding for a protein with the function of an ALAS, or an active fragment thereof or an antisense or complementary sequence thereof, in particular useful or ornamental plants, characterized in that the transgenic Plant is a monocot plant, preferably a corn plant.
  • Plant cells of this type contain one or more nucleic acid molecules (s) to be used according to the invention, these (s) preferably being linked to regulatory DNA elements which ensure transcription in plant cells, in particular a promoter.
  • Such cells can be distinguished from naturally occurring plant cells in that they have at least one chimeric gene according to the invention contain, which does not naturally occur in these cells, or in that such a molecule is integrated at a location in the genome of the cell where it does not naturally occur, ie in a different genomic environment.
  • Suitable NS constructs are produced for the transformation of plants, which contain a translatable sequence coding for a protein with ALAS activity.
  • DNA constructs for the expression of a heterologous gene in plants and to transform plants with this DNA construct.
  • DNA constructs are preferably produced by cloning a DNA sequence coding for ALAS under the control of a plant promoter in a plant transformation vector.
  • Binary plant transformation vectors such as e.g. B. pBIB or pPCV801 and their derivatives are suitable.
  • the gene coding for a protein with ALAS activity can also be inserted into the plant genome without a DNA sequence coding for an N-terminal plastid or mitochondrial targeting peptide under the control of a promoter active in plants, so that the primary translation product is directly in the cytoplasm active protein is expressed.
  • Plant cells or plastids are transformed with one of the DNA constructs described above, which is suitable for the functional expression of a gene coding for a protein with ALAS activity in plants.
  • one of the common genetic engineering methods for transforming plants for example Potrykus & Spangenberg (Eds.) "Gene Transfer to Plants” (1995) Springer-Verlag ISBN 3-540 58406-4
  • plastids for example Zoubenko et al. ( 1994) Nucleic Acids Research 22: 3819-1824).
  • Another subject of the invention is therefore a process for the production of transgenic plants, transgenic plant cells, transgenic plant parts, transgenic plant seeds, transgenic propagation material with modified 5-aminolevulinic acid biosynthesis containing one or more functionally active nucleic acid molecules coding for a protein with the function of an ALAS, selected from the Group of feedback-regulated ALAS, animal ALAS and bacterial ALAS, preferably a feedback-regulated ALAS, particularly preferably of ALAS from purple bacteria, of active fragments thereof or of an antisense or complementary sequence thereof, in which said nucleic acid molecules are stable into the plant piastom by plastid transformation to get integrated.
  • an ALAS selected from the Group of feedback-regulated ALAS, animal ALAS and bacterial ALAS, preferably a feedback-regulated ALAS, particularly preferably of ALAS from purple bacteria, of active fragments thereof or of an antisense or complementary sequence thereof, in which said nucleic acid molecules are stable into the plant piastom by plastid transformation to get integrated.
  • Another subject of the invention is therefore a process for the production of transgenic plants, transgenic plant cells, transgenic plant parts, transgenic plant seeds, transgenic propagation material with modified 5-aminolevulinic acid biosynthesis containing one or more functionally active nucleic acid molecules coding for a protein with the function of an ALAS, particularly preferably from ALAS from purple bacteria, from active fragments thereof or from an antisense or complementary sequence thereof, in which said nucleic acid molecules are stably integrated into the plant piastome by plastid transformation, characterized in that the transgenic plant is a monocot plant, preferably a maize plant.
  • Suitable recipient plants for a heterologous gene coding for a protein with ALAS activity are all agriculturally important monocotyledonous and dicotyledonous, preferably monocotyledonous, crop plants in which herbicidal inhibitors of the C5 pathway can be used to control undesirable accompanying vegetation, preferably maize and others Cereals such as wheat, rye, barley, millet and rice as well as cotton, tobacco, sugar beet, sugar cane, potatoes, rapeseed, sunflowers, soybeans, vegetables and fruit.
  • Cereals such as wheat, rye, barley, millet and rice as well as cotton, tobacco, sugar beet, sugar cane, potatoes, rapeseed, sunflowers, soybeans, vegetables and fruit.
  • the coding region can optionally be linked to DNA sequences which ensure localization in the respective compartment.
  • DNA sequences are known (see for example Braun et al., EMBO J. 11 (1992), 3219-3227; Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 846-850; Sonnewald et al ., Plant J. 1 (1991), 95-106).
  • the transgenic plant cells can be regenerated into whole plants using techniques known to those skilled in the art.
  • the plants obtainable by regeneration of the transgenic plant cells according to the invention are also the subject of the present invention.
  • the invention furthermore relates to plants which contain the transgenic plant cells described above.
  • the transgenic plants can in principle be plants of any plant species, i.e. both monocot and dicot plants. It is preferably useful or ornamental plants such as Cereals (rye, barley, oats, wheat, rice, corn), fruits and vegetables, cassava, potatoes, soy, sugar beet etc.
  • the invention also relates to propagation material of the plants according to the invention, for example fruits, seeds, tubers, rhizomes, seedlings and cuttings.
  • nucleic acid molecules to be used according to the invention are linked to regulatory DNA elements which ensure transcription in plant cells.
  • regulatory DNA elements which ensure transcription in plant cells.
  • These include promoters in particular.
  • any promoter active in plant cells can be used for the expression.
  • the promoter can be selected so that the expression is constitutive or only in a certain tissue, at a certain time in plant development or at a time determined by external influences.
  • the promoter can be homologous or heterologous with respect to the plant. Suitable promoters are, for example, the 35S RNA promoter of the Cauliflower Mosaic Virus and the ubiquitin promoter from maize for constitutive expression, the patatin gene promoter B33 (Rocha-Sosa et al., EMBO J.
  • a sink-specific expression e.g. potato tubers, beets, tomato fruit
  • a promoter which ensures expression only in photosynthetically active tissues for example the ST-LS1 promoter (Stockhaus et al., Proc. Natl. Acad. Sei. USA 84 (1987), 7943-7947; Stockhaus et al., EMBO J. 8 (1989), 2445-2451), all promoters constitutively active in plastids, for example the expression signal sequences of the psM cassette (Staub & Maliga (1993) EMBO Journal 12: 601-606; Zoubenko et al.
  • cloning vectors which contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells.
  • examples of such vectors are pBR322, pUC series, M13mp series and pACYC184.
  • the desired sequence can be introduced into the vector at a suitable restriction site.
  • the plasmid obtained is used for the transformation of E. coli cells.
  • Transformed E. coli Cells are grown in a suitable medium, then harvested and lysed.
  • the plasmid is recovered. Restriction analyzes, gel electrophoresis and other biochemical-molecular biological methods are generally used as the analysis method for characterizing the plasmid DNA obtained.
  • the plasmid DNA can be cleaved and DNA fragments obtained can be linked to other DNA sequences.
  • Each plasmid DNA sequence can be cloned into the same or different plasmids.
  • a variety of techniques are available for introducing DNA into a plant host cell. These techniques include the transformation of plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as a transformation agent, the fusion of protoplasts, the injection, the electroporation of DNA, the introduction of DNA using the biolistic method etc.
  • plasmids When injecting and electroporation of DNA into plant cells, there are no special requirements for the plasmids used. Simple plasmids such as e.g. PUC derivatives can be used. However, if whole plants are to be regenerated from such transformed cells, the presence of a selectable marker gene is necessary.
  • the Ti or Ri plasmid is used for the transformation of the plant cell, at least the right boundary, but often the right and left boundary of the Ti and Ri plasmid T-DNA as the flank region, must be connected to the genes to be introduced.
  • the DNA to be introduced must be cloned into special plasmids, either in an intermediate vector or in a binary vector.
  • the intermediate vectors can be integrated into the Ti or Ri plasmid of the agrobacteria by means of sequences which are homologous to sequences in the T-DNA by homologous recombination. This also contains the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate in agrobacteria. Using a helper plasmid, the intermediate vector can be transferred to Agrobacterium tumefaciens (conjugation). Binary vectors can replicate in E. coli as well as in Agrobacteria.
  • the agrobacterium serving as the host cell is said to contain a plasmid which carries a vir region.
  • the vir region is necessary for the transfer of the T-DNA into the plant cell; additional T-DNA may be present.
  • the agrobacterium transformed in this way is used to transform plant cells.
  • T-DNA for the transformation of plant cells is described in detail in EP 120 516; Hoekema, In: The Binary Plant Vector System Offsetdrukkerij Kanters B.V., Alblasserdam (1985), Chapter V; Fraley et al., Crit. Rev. Plant. Sci., 4, 1-46 and An et al. EMBO J. 4 (1985), 277-287.
  • plant explants can expediently be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes.
  • Whole plants can then be regenerated from the infected plant material (for example leaf pieces, stem segments, roots, but also protoplasts or suspension-cultivated plant cells) in a suitable medium, which can contain antibiotics or biocides for the selection of transformed cells.
  • the plants thus obtained can then be examined for the presence of the introduced DNA.
  • Other ways of introducing foreign DNA using the biolistic method or by protoplast transformation are known (cf. for example Willmitzer, L., 1993 Transgenic plants. In: Biotechnology, A Multi-Volume Comprehensive Treatise (HJ Rehm, G. Reed, A. Pühler, P. Stadler, eds., Vol. 2, 627-659, VCH Weinheim).
  • Transformed cells inherently contain a marker against inhibitors of GSAAT.
  • the transformed cells grow within the plant in the usual way (see also McCormick et al. Plant Cell Reports 5 (1986), 81-84).
  • the resulting plants can be grown normally and crossed with plants that have the same transformed genetic makeup or other genetic makeup.
  • the resulting hybrid individuals have the corresponding phenotypic properties. Seeds can be obtained from the plant cells.
  • Two or more generations should be grown to ensure that the phenotypic trait is stably maintained and inherited. Seeds should also be harvested to ensure that the appropriate phenotype or other characteristics have been preserved.
  • transgenic plants according to the invention can be used in practice in conjunction with a herbicide whose mechanism of action is based, at least in part, on an inhibition of the GSAAT and thus the C5 pathway.
  • the invention therefore also relates to a method for controlling unwanted vegetation in crops, characterized in that a crop is used which comprises one or more crops Has nucleic acid molecules coding for a protein of an ALAS according to the invention and applies a herbicidal agent to the location of this plant, the plant itself or its propagation material, the mechanism of action of which is based at least in part on a, preferably specific, inhibition of GSAAT.
  • herbicidal inhibitors of the plant C5 pathway can be found if the influence of a chemical compound on the activity of the plant GSAAT is determined and chemically diverse compounds are screened in individual or series tests. By automating a suitable GSAAT activity test, a large number of compounds can be examined in this way and the process can thus be made practical.
  • the subject of the invention is therefore also a, preferably automated, method for determining the effector effect of a test substance with regard to the activity of a GSAAT, in which a) the enzymatic activity of the GSAAT is determined in the absence of a test substance; b) the enzymatic activity of the GSAAT is determined in the presence of a test substance; and c) compares the enzymatic activities determined under a) and b).
  • the method is suitable for finding specific inhibitors or activators (ie effectors) of the enzymatic activity of the GSAAT, so that substances can be identified which have a potential herbicidal or growth-inhibiting but also growth-promoting effect.
  • the chemical compound to be examined is preferably used in concentrations between 10 "9 M and 10 " 3 M, and particularly preferably in concentrations between 10 "7 M and 10 " 4 M used.
  • the enzyme inhibition or enzyme activation (i.e. the effector effect) can be quantified by a simple comparison of the catalytic activity of the GSAAT in the absence and in the presence of the test substance to be investigated under otherwise identical test conditions in a manner known to the person skilled in the art.
  • Various biochemical measurement methods can be used to determine the activity of the GSAAT, by means of which either the formation of the reaction products of the reaction catalyzed by the GSAAT, eg. B. ALA, or a decrease in the concentration of the enzyme substrates such as glutamate semialdehyde can be measured, e.g. by an end point determination or after enzymatic conversion of the substrates, which may or may not have been radioactively labeled or provided with other common markers or can be detected by subsequent reactions, e.g. through coupled enzymatic reactions.
  • the enzyme substrates such as glutamate semialdehyde
  • the methods according to the invention for determining the effector effect of test substances can be carried out with purified GSAAT, but also with whole cells of a recombinant organism which expresses the GSAAT recombinantly, with GSAAT-containing extracts from this organism or enriched GSAAT-containing fractions from this organism.
  • Bacterial, insect and yeast cells may be mentioned as the preferred recombinant host organism.
  • a GSAAT isolated from plant tissue or plant cell cultures can be used.
  • the subject of the invention is therefore also the use of a method according to the invention and the use of a, preferably recombinantly produced, protein with the function of a GSAAT for identifying effectors of the GSAAT, preferably in an automated method, for example in a so-called high-speed screening, the implementation of which makes it possible to automate the Procedure for determining the activity of the enzyme is required.
  • Effectors according to the invention or identified according to the invention influence (inhibit) the activity of the enzyme, preferably under the test conditions described, preferably by at least 30%, particularly preferably by at least 50%.
  • effectors that can be identified by means of the method according to the invention, i.e. Activators or inhibitors of the enzymatic activity of the GSAAT, in particular pesticidal or herbicidally active effectors of the vegetable GSAAT, especially structural analogs of glutamate semialdehyde, glutamate or 5-aminolevulinate and their use as pesticides or herbicides.
  • GSAAT glutamate 1 semialdehyde
  • the GSAAT from plants is preferably used to identify effective enzyme inhibitors, particularly preferably the GSAAT from Arabidopsis thaliana (Seq. ID No. 5) or Hordeum vulgare (Seq. ID No. 6).
  • the GSAAT can either be isolated from the corresponding plants in a manner known to the person skilled in the art or can also be produced recombinantly in transgenic host cells on the basis of cDNA known from the literature.
  • glutamate-1-semialdehyde instead of glutamate-1-semialdehyde, other compounds, such as. B. 4,5-diaminovaleric acid, 4,5-dioxovaleric acid and in particular mixtures of these compounds can be used.
  • the enzymatic reaction can be influenced by adding pyridoxal phosphate or pyridoxamine phosphate.
  • GSAAT activity test A particularly suitable, exemplary embodiment of the GSAAT activity test is shown below, which is also particularly advantageous for an automated execution of the GSAAT test:
  • Glutamate-1-semialdehyde can be converted to 5-aminolevulinic acid in a reaction buffer in the pH range from pH 6 to pH 8 by an enzyme with GSAAT activity.
  • the 5-aminolevulinic acid can then be detected using two derivatization steps.
  • the solution is a compound of the general formula R-CO-CH 2 -CO-R ', such as acetylacetone, acetoacetic acid, amides and salts of acetoacetic acid, acetoacetic acid esters (methyl ester, ethyl ester, isopropyl ester, etc.) or derivatives of these compounds, in added at least a ten-fold molar excess to the expected amount of 5-aminolevulinic acid.
  • the mixture is then heated, for example, for a few minutes (80 ° C to the boiling point of the mixture) or incubated at 12 ° C to 80 ° C for 15 minutes or longer.
  • a condensation reaction takes place between the aminolevulinic acid and the added compound to form a pyrrole derivative.
  • the concentration of the pyrrole derivative is then determined, for example, by adding Ehrlichs Reagent (for example 1 volume) determined.
  • Ehrlichs Reagent for example 1 volume
  • the pyrrole de vat forms a colored complex with the 4-diaminobenzaldehyde in Ehrlich's reagent, the concentration of which can be determined photometrically by means of an absorption measurement.
  • a suitable wavelength for determining absorption is, for. B. between 530 and 550 nm.
  • the enzymatically formed amount of 5-aminolevulinic acid can be calculated using a calibration series with 5-aminolevulinic acid solutions of known concentrations, which are derivatized in the same way.
  • compositions of the reagents or the concentrations of salts, substrates and proteins, the pH values, the temperatures, the batch volumes and the wavelengths for measurement or detection can vary widely.
  • a person skilled in the art can determine the effector, ie activatorial or inhibitory properties of chemical compounds on the activity of the GSAAT in a variety of known ways.
  • a variety of methods are available to the person skilled in the art for checking the effect of a GSAAT inhibitor on plants in vivo.
  • the substances to be investigated for example defined chemical compounds, but also heterogeneous substance mixtures
  • auxiliaries such as wetting agents or solvents, can be used.
  • the plants are rated. Substances that damage a plant through selective inhibition of the GSAAT or the C5 pathway cause at least one characteristic symptom.
  • Chlorosis often develops after application, which can be particularly pronounced in the newly formed tissue and which can, for example, pass into necrosis due to the action of light.
  • Other symptoms can be a depression of growth or a very rapid death of the plant.
  • the symptoms vary depending on the plant species, depending on their different sensitivity and depending on the properties of the inhibitor.
  • a simple and practical possibility for an in vivo test is the Lemna test described in Example 8.
  • the concentration range of the test substance preferably being in the range from 10 "6 to 10 * 4 represents a rational method for the development of herbicides, the effect of which is based on an inhibition of plant GSAAT.
  • the invention therefore also relates to a method for finding herbicidal active compounds, characterized in that the test substance to be examined is tested for an effector effect against GSAAT as described above and preferably also subjected to a Lemna test.
  • the invention relates to the use of a compound which, in the test methods described, has an at least 30%, preferably at least 50%, inhibitory activity on effector properties compared to GSAAT and is preferably active in the Lemna test as a herbicide.
  • Active means preferably the appearance of chlorotic tissue, particularly preferably the appearance before chlorotic tissue and a growth depression of the plant, preferably within ten, particularly preferably within seven days.
  • the invention also relates to a process for combating undesirable plant growth in crops, characterized in that a herbicidal composition is applied to the site of the crop, the crop or its propagation material, comprising a compound which, in the test method described above, has a concentration range of 10 '7 to 10 "4 molar an at least 30%, preferably at least 50%, inhibitory effect compared to GSAAT and, preferably, is active in the Lemna test.
  • the useful plants are preferably transgenic plants according to the invention with modified 5-levulinic acid biosynthesis.
  • ALAS1 has the sequence 5'-gactgtgcatgcaggactacaatctggcactc-3 ', carries a Sphl restriction site at the 5' end and is derived in the 3 'region from positions 1950 to 1967 of gene bank entry L07490 (SEQ ID No. 1).
  • ALAS2 has the sequence 5'-ctgactctgcagtcaggcaacgacctcggc-3 ', carries a PstI restriction site at the 5' end and is derived in the 3 'region from positions 3170 to 3153 of gene bank entry L07490.
  • PCR polymerase chain reaction
  • 5 ⁇ l of a stationary culture of Rhodobacter sphaeroides strain ATCC # 35054 were cultured in a total volume of 50 ⁇ l given in the catalog of the American Type Culture Collection, Manassas, Virginia 20110-2209, USA), 10 nmol dATP, dCTP, dGTP and dTTP as well as 25 pmol each of primers ALAS1 and ALAS2 mixed.
  • the reaction mixture was 1/10 volume 10x Taq buffer (100 mM Tris / HCl pH 9.0, 500 mM KCI, 15 mM MgCl 2 ,
  • the vector pGEM3Zf- Promega was cleaved with Sphl and Pstl and the approximately 3100 bp vector fragment was isolated.
  • the Sphl / Pstl vector fragment was ligated to the 1235 b long Sphl / Pstl fragment of the hemA-PCR product.
  • Escherichia coli XL-1 Blue (Stratagene) was transformed with the ligation product.
  • the 1235 b long Sphl / Pstl fragment from pALASI was ligated with the 222 bp Pstl (2335) / Hindlll (2557) fragment from p35StpASN and the 3438 bp long Hindlll (2557) / Sphl (1199) fragment from p35StpASN.
  • the sequence of the vector p35StpANS is given in sequence ID NO. 8, the plasmid map in FIG. 1.
  • the ligation product of the three fragments was named pALAS2.
  • the sequence coding for ALAS from Rhodobacter sphaeroides at the 5 'end via the Sphl cleavage site in the reading frame is fused with a sequence coding for a modified chloroplastic targeting sequence.
  • This sequence is derived from the chloroplastic targeting sequence of the small subunit of pea ribulose bisphosphate carboxylase and contains an internal sequence duplication corresponding to positions 985 to 1041 in p35StpASN, which are repeated as positions 1045 to 1101 in p35StpASN (cf. Seq. ID No. 8).
  • the transcription of the fusion gene is regulated via the CaMV35S promoter.
  • the approximately 2.2 kb cassette containing the 35S promoter, targeting sequence, ALAS gene and 35S terminator was cut out of pALAS2 using EcoRI and the overhanging DNA ends of this fragment were filled in using T4 DNA polymerase.
  • the vector pcva13 (Seq. ID. No. 9, plasmid map in FIG. 2) was linearized with SnaBI, dephosphorilized with alkaline phosphatase and ligated with the approx. 2.2 kb long, filled-in fragment from pALAS2.
  • pALAS3f a plasmid in which the reading direction of the hemA gene and the PAT gene are in the same direction was designated as pALAS3f (cf. FIG. 3).
  • transgenic maize plants which contain an expression cassette for the hemA gene from Rhodobacter sphaeroides
  • a transformation was carried out as described in EP-A 0 469 273, with pALAS3f being used differently as the DNA to be transferred.
  • 41 independent maize Get transformants Plants were regenerated as described from these lines designated as M23T1, M25T1 to M25T13 and M27T1 to M27T27.
  • the presence of the complete hemA gene was detected in all transgenic plants by means of PCR using the oligodeoxynucleotides ALAS1 and ALAS2 (see Example 1) as PCR primers.
  • the tolerance threshold of the non-transformed maize line against the GSAAT inhibitor 3-amino-2,3-dihydrobenzoic acid was determined.
  • the maize seeds were surface-sterilized by washing them under sterile conditions first in 70% ethanol for 1 min, then in 5% sodium hypochlorite, 0.1% Tween 20 for 20 min and then briefly in sterile water for six times.
  • the seeds were then sterile on Murashige & Skoog medium (micro and macronutrients, Sigma GmbH # M5524) containing 90 g / l sucrose and 8 g / l agar and put for six days at room temperature under daylight fluorescent tubes in 12 h light / Dressed darkly for 12 h until the second leaf became visible.
  • the plantlets were placed on fresh medium with various concentrations of 3-amino-2,3-dihydrobenzoic acid.
  • transgenic lines to 3-amino-2,3-dihydrobenzoic acid is determined in comparison with the non-transgenic starting line.
  • five regenerated plants per line which visually correspond in size and rooting to the seedlings described above after six days of germination, on media without 3-amino-2,3-dihydrobenzoic acid (one plant) and with 100 ⁇ M 3-amino-2, 3-dihydrobenzoic acid (four plants) implemented and cultivated further. All regenerated plants of the non-transgenic line show, as before, under the action of 3-amino-2,3-dihydrobenzoic acid marked chlorosis and reduced biomass production compared to the untreated control.
  • the transgenic lines show a phenotype comparable to the non-transgenic plants under these conditions.
  • the ALAS gene according to the invention none of the regenerated plants in the presence of 100 ⁇ M 3-amino-2,3-dihydrobenzoic acid shows chlorosis or reduced growth compared to their respective untreated control on medium without 3-amino-2,3- dihydrobenzoic acid.
  • the mature GSAAT from Hordeum vulgare was genetically engineered in Escherichia coli using Sequence ID No. 6.
  • Escherichia coli strain TG1 (Gibson (1984) PhD Thesis, Cambridge, UK) was used simultaneously with the expression plasmid pATE19 (Berry-Lowe et al. (1992) Plant Physiology 99: 1597-1603) and the plasmid pGroESL (Goloubinoff et al (1989) Nature 337: 44-47).
  • Transformed clones were always cultivated in LB medium (10 g / l tryptone, 5 g / IHefe extract, 5 g / l NaCl) with 100 mg / l ampicillin and 30 mg / l chloramphenicol.
  • 100 ml of medium were inoculated with a TG1 / pATE19 / pGroESL clone and incubated for 14 h at 37 ° C. with shaking in a culture flask.
  • isopropyl-bD-thio-galactopyranoside was immediately added to a final concentration of 0.5 mM.
  • the incubation temperature was reduced to 28 ° C.
  • the cells were harvested by centrifugation (4200 g, 20 min, 4 ° C.).
  • the cell sediment was resuspended in 150 ml buffer A (50 mM tricin / NaOH pH 7.9, 25 mM MgCl 2 ).
  • the cells were then disrupted by three passages through the French Press homogenizer (French Pressure Cell Press and 35 ml digestion cell from SLM Instruments, Inc., Rochester NY 14625 USA) at 16000 psi and 4 ° C. The homogenate was then centrifuged for 30 min at 25000 g and 4 ° C. The clear supernatant was subjected to anion exchange chromatography.
  • French Press homogenizer Frnch Pressure Cell Press and 35 ml digestion cell from SLM Instruments, Inc., Rochester NY 14625 USA
  • a DEAE-Sepharose Fast Flow column (Pharmacia GmbH, Freiburg) with a bed volume of 500 ml was equilibrated with buffer A. The clear supernatant of the digested cells was applied to this column. The column was then rinsed first with 250 ml of buffer A and then with 1500 ml of buffer B (50 mM tricin / NaOH pH 7.9, 25 mM MgCl 2 , 20 mM NaCl). The elution of the recombinant GSAAT took place with 750 ml buffer C (50 mM tricin / NaOH pH 7.9, 25 mM MgCl 2 , 100 mM NaCl). The eluate was collected in fractions of 25 ml and the fractions containing functional GSAAT were determined by means of a GSAAT activity test on samples from the fractions. 25 nkat GSAAT were obtained from 5 l expression culture.
  • the activity of the GSAAT was demonstrated by photometric detection of the derivatized reaction product 5-aminolevulinic acid.
  • the activity test was carried out in a 96-well flat-bottom microtiter plate (F-form) made of polystyrene.
  • F-form microtiter plate
  • the desired number of individual measurements could be carried out in parallel in the wells of the microtiter plate (wells).
  • MTP microtiter plate
  • the mixture was incubated at 20 ° C. for 30 min. 25 ⁇ l of ethyl acetoacetate were then added immediately, the mixture was thoroughly mixed and incubated at 40 ° C. for 30 min. Immediately afterwards, 100 ⁇ l Ehrlich's reagent (see below) was added and the mixture was incubated at 20 ° C. for 30 min. After the incubation had ended, the absorption of the solution at a wavelength of 540 nm was determined immediately with the aid of a microtiter plate photometer.
  • the blank value (see below) was first subtracted from the absorption of the batch to be determined.
  • the concentration of 5-aminolevulinic acid in the reaction mixture at the time immediately before the addition of the acetoacetic acid ethyl ester was calculated from the difference between the measured value and the blank value using a calibration series.
  • the calibration series was generated by first incubating 100 ⁇ l of differently concentrated 5-aminolevulinate solutions in 250 mM BisTris / HCl pH 6.5 for 30 min at 20 ° C., then mixing with 25 ⁇ l ethyl acetoacetate and 30 min at 40 ° C.
  • the concentration of 5-aminolevulinic acid in the 100 ⁇ l 250 mM BisTris / HCl pH 6.5 is varied in parallel between 0 ⁇ M and 150 ⁇ M (0 ⁇ M, 5 ⁇ M, 10 ⁇ M, 20 ⁇ M, 50 ⁇ M, 100 ⁇ M, 150 ⁇ M).
  • a parallel GSAAT activity test was used to determine a blank value (see above) as a reference to the measured absorption value of a GSAAT reaction carried out, in which 1.) the enzymatic activity of the GSAAT was blocked and the 2.) was otherwise carried out under exactly the same conditions as the approach to be compared.
  • 10 ⁇ l of a solution of 10 mM aminooxyacetic acid in 25% (v / v) dimethyl sulfoxide / water is initially introduced together with the enzyme solution instead of 10 ⁇ l 25% (v / v) dimethyl sulfoxide / water (see above) .
  • Composition of Ehrlich's reagent is initially introduced together with the enzyme solution instead of 10 ⁇ l 25% (v / v) dimethyl sulfoxide / water (see above) .
  • the solutions in the wells of the MTPs were then mixed with 100 ⁇ l enzyme solution (25 pkat / ml recombinant GSAAT from Hordeum vulgar, 250 mM BisTris / HCl pH 6.5).
  • the enzymatic reaction was started in all wells of an MTP at the same time by adding 5 ⁇ l of 1.8 mM glutamate-1-semialdehyde dissolved in 100 mM HCl.
  • the further steps were identical to the procedure described in Example 2 after the start of the enzymatic reaction.
  • the activity of the non-inhibited GSAAT could then be determined for each MTP from the mean of the measurement results for the wells with the control reactions and the mean of the wells with the blank values. Likewise, the GSAAT activity was determined for each well of this MTP in which a substance to be examined was used by subtracting the mean value of the blank values. By comparing the activity of the activity of the GSAAT in the presence of a substance to be investigated and the activity in the absence of the substance to be investigated (control reactions), it was determined whether the substance is effector, i.e. inhibits or activates the GSAAT activity test. Compounds that cause a relative reduction in GSAAT activity by more than 30% compared to the control reactions have been investigated more closely as potential effectors.
  • the potency of an effector of the GSAAT was determined by carrying out the GSAAT test (cf. Example 2) in the presence of different concentrations of the effector in the reaction solution. Concentrations of 1 nM, 3 nM, 10 nM, 30 nM, 100 nM, 300 nM, 1 ⁇ M, 3 ⁇ M, 10 ⁇ M, 30 ⁇ M, 100 ⁇ M and 300 ⁇ M of the effector were used.
  • the inhibitor constants were calculated on the basis of the activities derived from the measured values using the methods described in detail by Bergmeyer (basics of enzymatic analysis; ed. By Hans Ulrich Bergmeyer, Verlag Chemie Weinheim, New York, 1977, ISBN 3- 527-25677-6), the constants for activators could be determined in an analogous manner.
  • the phytotoxic effects of GSAAT inhibitors could also be determined in vivo by treating Lemna cultures.
  • Lemna gibba was added to this in sterile culture solution (0.4 g / l KNO 3 , 0.8 g / l CaCl 2 * 2 H 2 O, 0.366 g / l MgSO 4 * 7 H 2 O, 0.2 g / l KH 2 PO 4 , 2 ml / 1 solution I (2.23 g / l MnSO 4 * 4 H 2 O, 83 mg / l KJ, 2.5 mg / l CoCI 2 * 6 H 2 O, 0.86 g / I ZnS0 4 * 7H 2 O, 2.5 mg / l CuSO 4 * 5 H 2 O, 0.62 g / l H 3 BO 3 , 25 mg / l Na 2 MoO 4 * 2 H 2 O) and 2 ml / 1 solution II (14.92 g / l Na-EDTA, 10.92 g / l FeSO 4 * 7 H 2 O)).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé de production de plantes transgéniques par biosynthèse modifiée d'acide 5-aminolévulinique, de cellules de plantes transgéniques, de parties de plantes transgéniques, de graines de plantes transgéniques, et de matériau de multiplication transgénique. Ledit procédé se caractérise en ce qu'une ou plusieurs molécules d'acide nucléique codant pour une protéine présentant la fonction d'une acide 5-aminolévulique synthase (ALAS), sélectionnée dans le groupe des ALAS régulées par rétroaction, des ALAS animales et des ALAS bactériennes, d'un fragment actif d'une telle enzyme ou d'une séquence antisens ou complémentaire de celle-ci, sont intégrées dans le génome végétal. Des effecteurs de la biosynthèse naturelle de l'acide 5-aminolévulique sont trouvés dans des plantes selon un procédé permettant de déterminer l'efficacité, en tant qu'effecteur, d'une substance DC par rapport à l'activité d'une glutamate 1-semialdéhyde amino transférase (GSAAT), procédé selon lequel: (a) on détermine l'activité enzymatique de la GSAAT en présence d'une substance d'essai; (b) on détermine l'activité enzymatique de la GSAAT en l'absence d'une substance d'essai; et (c) on compare les activités enzymatiques déterminées lors des opérations (a) et (b).
EP98964495A 1997-12-10 1998-12-10 Procede de production de plantes transgeniques par biosynthese modifiee d'acide 5-aminolevulinique, et procede d'identification d'effecteurs de la synthese d'acide 5-aminolevulinique Withdrawn EP1038012A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19754929 1997-12-10
DE19754929A DE19754929A1 (de) 1997-12-10 1997-12-10 Verfahren zur Herstellung transgener Pflanzen mit veränderter 5-Aminolävulinsäure-Biosynthese und Verfahren zur Identifizierung von Effektoren der 5-Aminolävulinsäure Synthese
PCT/EP1998/008028 WO1999029880A2 (fr) 1997-12-10 1998-12-10 Procede de production de plantes transgeniques par biosynthese modifiee d'acide 5-aminolevulinique, et procede d'identification d'effecteurs de la synthese d'acide 5-aminolevulinique

Publications (1)

Publication Number Publication Date
EP1038012A2 true EP1038012A2 (fr) 2000-09-27

Family

ID=7851464

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98964495A Withdrawn EP1038012A2 (fr) 1997-12-10 1998-12-10 Procede de production de plantes transgeniques par biosynthese modifiee d'acide 5-aminolevulinique, et procede d'identification d'effecteurs de la synthese d'acide 5-aminolevulinique

Country Status (7)

Country Link
US (2) US6603062B1 (fr)
EP (1) EP1038012A2 (fr)
JP (1) JP2001526041A (fr)
AU (1) AU1966999A (fr)
CA (1) CA2313706A1 (fr)
DE (1) DE19754929A1 (fr)
WO (1) WO1999029880A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916971B1 (en) 1999-07-30 2005-07-12 Rebecca E. Cahoon Polynucleotides encoding aminolevulinic acid biosynthetic enzymes
AU6509100A (en) * 1999-07-30 2001-02-19 E.I. Du Pont De Nemours And Company Polynucleotides encoding aminolevulinic acid biosynthetic enzymes
CN100402647C (zh) 2000-03-03 2008-07-16 麒麟麦酒株式会社 改进的启动子及其应用
JP5256020B2 (ja) * 2005-04-08 2013-08-07 バイエル・クロップサイエンス・エヌ・ヴェー エリートイベントａ２７０４−１２、ならびに生物サンプル中の該イベントを同定するための方法およびキット
CN1322132C (zh) * 2005-04-19 2007-06-20 浙江大学 生产5－氨基乙酰丙酸的工程菌及其构建方法
WO2007024782A2 (fr) * 2005-08-24 2007-03-01 Pioneer Hi-Bred International, Inc. Compositions assurant une tolerance a de multiples herbicides et methodes d'utilisation
CN103468736A (zh) * 2013-09-27 2013-12-25 浙江大学 一种荚膜红细菌hemA基因的胞内高活性表达方法
CN103911317B (zh) * 2014-03-07 2016-01-20 中国农业科学院生物技术研究所 一种具有耐草甘膦功能的细菌及其应用
US11859196B2 (en) 2016-03-15 2024-01-02 National Research Council Of Canada Modulating drought tolerance in Brassicaceae using the Kanghan gene family
CA3017594A1 (fr) 2016-03-15 2017-09-21 National Research Council Of Canada Modulation des reponses au stress abiotique des plantes a l'aide de la famille des genes kanghan
CN111454988B (zh) * 2020-05-11 2022-02-15 湖南省植物保护研究所 一种提高植物抗虫能力的方法及其植物表达载体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020209A2 (fr) * 1995-12-01 1997-06-05 E.I. Du Pont De Nemours And Company Procede et appareil de microcriblage de produits agricoles
DE19650216A1 (de) * 1996-12-04 1998-06-10 Inst Pflanzengenetik & Kultur Verfahren zur Beeinflussung der Chlorophyllbiosynthese in Pflanzen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9929880A2 *

Also Published As

Publication number Publication date
WO1999029880A3 (fr) 1999-10-07
CA2313706A1 (fr) 1999-06-17
JP2001526041A (ja) 2001-12-18
US20030204873A1 (en) 2003-10-30
DE19754929A1 (de) 1999-06-17
US6603062B1 (en) 2003-08-05
AU1966999A (en) 1999-06-28
WO1999029880A2 (fr) 1999-06-17

Similar Documents

Publication Publication Date Title
DE69233353T2 (de) Transitpeptid-dna sequenz
HU213580B (en) Method for producing by genetic engineering plant and plant cells resistant to glutamine-synthetase inhibitors, and method for protecting plants by elimination of weeds and fungi
US5145777A (en) Plant cells resistant to herbicidal glutamine synthetase inhibitors
KR20000053140A (ko) 제초제에 견디는 식물
WO1998008963A1 (fr) Combinaisons geniques conferant au mais la tolerance aux herbicides
WO1998045456A1 (fr) Sequences d'adn codant pour une 2-desoxyglucose-6-phosphate (2-dog-6-p) phosphatase et servant de marqueur de selection chez les vegetaux
AU576402B2 (en) Plant cells resistant to herbicidal glutamine synthetase inhibitors
WO1987005327A1 (fr) Cellules vegetales resistant aux inhibiteurs de glutamine synthetase utilises en tant qu'herbicides
WO1999029880A2 (fr) Procede de production de plantes transgeniques par biosynthese modifiee d'acide 5-aminolevulinique, et procede d'identification d'effecteurs de la synthese d'acide 5-aminolevulinique
DE19502053A1 (de) Verfahren und DNA-Moleküle zur Steigerung der Photosyntheserate in Pflanzen, sowie Pflanzenzellen und Pflanzen mit gesteigerter Photosyntheserate
DE112009001976T5 (de) Transgene Pflanzen mit erhöhtem Ertrag
DE19752647C1 (de) Reduktiion des Chlorophyllgehaltes in Ölpflanzensamen
EP0977878B1 (fr) Sequences d'adn codant pour la sous-unite chld de chelatases vegetales de magnesium pour determiner leurs effets
DE69837396T2 (de) Genetisches verfahren
AU2002359021A1 (en) A method for increasing resistance of monocot plants against abiotic stresses
EP0927246A2 (fr) Adenylosuccinate-synthetase
DE19914792A1 (de) Metabolische Selektionsmarker für Pflanzen
DE60028751T2 (de) Herbizidresistente pflanzen
EP0987330A1 (fr) Modification du developpement et de la differentiation des plantes par moyen de l'expression tissue-specifique du gene Deac
AU609391C (en) Plant cells resistant to herbicidal glutamine synthetase inhibitors
CN117586973A (zh) Hsl蛋白、基因、载体、细胞、组合物及应用、提高作物除草剂抗性的方法
WO2001036606A2 (fr) Production de plantes resistant aux inhibiteurs peroxydants de la protoporphyrinogene-9-oxydase
WO2001009355A2 (fr) S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE VEGETALE, VEGETAUX A TENEUR EN CHLOROPHYLLE VARIABLE ET/OU A TOLERANCE AUX HERBICIDES VARIABLE, ET PROCEDE DE PRODUCTION
WO2001064861A2 (fr) Synthetase 1 de pyrophosphate de phosphoribosyle en tant que cible herbicide
WO2002060939A2 (fr) Procede pour augmenter la concentration de composes sulfures dans des plantes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000710

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAYER CROPSCIENCE GMBH

17Q First examination report despatched

Effective date: 20030514

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060609